Welcome to LookChem.com Sign In|Join Free
  • or
3-Bromo-5-nitrobenzonitrile is a chemical compound characterized by its molecular formula C7H3BrN2O2. It manifests as a yellow crystalline solid and is recognized for its utility as an intermediate in the synthesis of a range of products including pharmaceuticals, agrochemicals, and dyes. 3-Bromo-5-nitrobenzonitrile is a valuable building block in organic synthesis, particularly for the preparation of biologically active compounds. Its high reactivity allows it to participate in various chemical reactions such as nucleophilic substitution, making it a common feature in medicinal chemistry research. Due to its toxic nature and potential to cause irritation to the skin, eyes, and respiratory system, careful handling is imperative.

49674-15-9

Post Buying Request

49674-15-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

49674-15-9 Usage

Uses

Used in Pharmaceutical Industry:
3-Bromo-5-nitrobenzonitrile is used as a synthetic intermediate for the production of various pharmaceuticals, leveraging its reactivity to form the backbone of multiple medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Bromo-5-nitrobenzonitrile is utilized as a precursor in the synthesis of different agrochemicals, contributing to the development of products designed to protect crops and enhance agricultural yields.
Used in Dye Industry:
3-Bromo-5-nitrobenzonitrile is employed as a chemical intermediate in the dye industry, playing a role in the creation of diverse dyes used across various applications.
Used in Organic Synthesis:
3-Bromo-5-nitrobenzonitrile is used as a versatile building block in organic synthesis, serving as a key component in the preparation of biologically active molecules for research and development purposes.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-Bromo-5-nitrobenzonitrile is applied as a reactive intermediate that facilitates the exploration of new chemical space and the development of potential therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 49674-15-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,9,6,7 and 4 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 49674-15:
(7*4)+(6*9)+(5*6)+(4*7)+(3*4)+(2*1)+(1*5)=159
159 % 10 = 9
So 49674-15-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H3BrN2O2/c8-6-1-5(4-9)2-7(3-6)10(11)12/h1-3H

49674-15-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Bromo-5-nitrobenzonitrile

1.2 Other means of identification

Product number -
Other names 3-Brom-5-nitrobenzonitril

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:49674-15-9 SDS

49674-15-9Relevant academic research and scientific papers

COMPOUNDS, COMPOSITIONS AND METHODS OF USE

-

Page/Page column 250-251, (2020/07/06)

Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.

NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

-

Paragraph 0509, (2020/08/25)

Compound of formula (I): wherein A1, A2, Ra, Rb, Rc, Rd, R3, R4, X, Y and G are as defined in the description, and their use in the manufacture of medicaments.

Potent mGluR5 antagonists: Pyridyl and thiazolyl-ethynyl-3,5-disubstituted- phenyl series

Alagille, David,Dacosta, Herve,Chen, Yelin,Hemstapat, Kamondanai,Rodriguez, Alice,Baldwin, Ronald M.,Conn, Jeffrey P.,Tamagnan, Gilles D.

, p. 3243 - 3247 (2011/07/07)

We report the synthesis of four series of 3,5-disubstituted-phenyl ligands targeting the metabotropic glutamate receptor subtype 5: (2-methylthiazol-4-yl) ethynyl (1a-j,), (6-methylpyridin-2-yl)ethynyl (2a-j), (5-methylpyridin-2-yl) ethynyl (3a-j,), and (pyridin-2-yl)ethynyl (4a-j,). The compounds were evaluated for antagonism of glutamate-mediated mobilization of internal calcium in an mGluR5 in vitro assay. All compounds were found to be full antagonists and exhibited low nanomolar to subnanomolar activity.

(3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING

-

Page/Page column 71; 110-111, (2009/05/29)

The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 49674-15-9